Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
10/28/1999 | WO1999054454A1 Mutants of the mycobacterium species and use of the same for screening for antibiotics vectors |
10/28/1999 | WO1999054441A1 Efficient purification of adenovirus |
10/28/1999 | WO1999054440A1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF |
10/28/1999 | WO1999054360A1 Substance with antithrombotic activity and method for detecting glycokallidin |
10/28/1999 | WO1999054353A2 Human nucleic acid sequences of normal uterus tissue |
10/28/1999 | WO1999054351A1 Edg family gene, human h218 |
10/28/1999 | WO1999054349A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
10/28/1999 | WO1999054348A1 Rapidly degrading gfp-fusion proteins and methods of use |
10/28/1999 | WO1999054343A2 Novel molecules of the t139-related protein family and uses thereof |
10/28/1999 | WO1999054166A1 Capacitive sensor assembly with soot build-up inhibiting coating |
10/28/1999 | WO1999053953A2 Methods and products related to metabolic interactions in disease |
10/28/1999 | WO1999053952A1 Method for producing a specific antiserum against the universal tumorous antigen and method for diagnosing malignant tumours using said antiserum |
10/28/1999 | WO1999053938A1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof |
10/28/1999 | WO1999053917A1 Cannabinoids as antioxidants and neuroprotectants |
10/28/1999 | WO1999053840A1 Detection of cancerous lesions by their effect on the spatial homogeneity of skin temperature |
10/28/1999 | WO1999053757A1 Autoantigenic fragments, methods and assays |
10/28/1999 | WO1999045142A3 Agent and method for detecting chemical substances |
10/28/1999 | WO1999042839A3 Treating cancer |
10/28/1999 | WO1999042827A3 Device for detecting oligonucleotide and/or polynucleotide hybridization |
10/28/1999 | WO1999042604A8 Methods of screening compounds for bioactivity in organized tissue |
10/28/1999 | WO1999042127A3 Receptor derived peptides as modulators of receptor activity |
10/28/1999 | WO1999041584A3 METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY |
10/28/1999 | WO1999040946A3 Methods and compositions for modulating leptin activity |
10/28/1999 | WO1999037763A9 Novel nucleic acid molecules correlated with the rhesus weak d phenotype |
10/28/1999 | WO1999037299B1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer |
10/28/1999 | WO1999036564A9 Multiplexed analysis of clinical specimens apparatus and methods |
10/28/1999 | WO1999035497A3 A device for testing liquids |
10/28/1999 | WO1999035255A3 Compositions and methods for regulated secretion from neuroendocrine cell lines |
10/28/1999 | WO1999035245A3 Methods for preparing and using immortalized human neuroendocrine cells |
10/28/1999 | WO1999029898A3 Method for identifying nucleic acids by means of matrix-assisted laser desorption/ionisation mass spectrometry |
10/28/1999 | WO1999008695A8 FLUORESCENT AMYLOID Aβ PEPTIDES AND USES THEREOF |
10/28/1999 | WO1998003497A9 Covalently immobilised fluoroionophores for optical ion sensors |
10/28/1999 | DE19903693A1 Protease zur Aktivierung des Gerinnungsfaktors VII Protease for activation of coagulation factor VII |
10/28/1999 | DE19854316A1 Container for the aids required for rapid analysis tests outside a laboratory |
10/28/1999 | DE19833844A1 Pre-operative determination of the risk of intra-operative bleedings |
10/28/1999 | DE19818790A1 Preparation of an immuno-adsorption matrix, useful for diagnostic and therapeutic purposes |
10/28/1999 | DE19818620A1 New polypeptides and their nucleic acids, useful for treatment of bladder tumor and identification of therapeutic agents |
10/28/1999 | DE19818329A1 Determining the change in concentration of a chemical substance detected by a sensor |
10/28/1999 | DE19818192A1 Eximer lamp excited sensor for measuring the quantity of oil remaining in water recovered from a sub-sea separation tank |
10/28/1999 | DE19818176A1 Process for marking liquids, e.g. fuels |
10/28/1999 | DE19818077A1 Fixing substrate molecules in gel matrixes |
10/28/1999 | DE19817963A1 Verfahren und Reagenz zur störungsfreien Bestimmung von Eisen Method and reagent for interference-free determination of iron |
10/28/1999 | DE19817853A1 Personal gas tracing device with signal transmission |
10/28/1999 | DE19814659C1 Continuous measurement of chemical compounds in a mixture |
10/28/1999 | DE19813633C1 Determining the probability of the occurrence of bone metastasis |
10/28/1999 | CA2658218A1 Improved immunodiagnostic assays using reducing agents |
10/28/1999 | CA2329626A1 Cannabinoids as antioxidants and neuroprotectants |
10/28/1999 | CA2329495A1 Autoantigenic fragments, methods and assays |
10/28/1999 | CA2329223A1 Method for determining a gushing factor for a beverage |
10/28/1999 | CA2328888A1 Rapidly degrading gfp-fusion proteins and methods of use |
10/28/1999 | CA2328704A1 Detection of cancerous lesions by their effect on the spatial homogeneity of skin temperature |
10/28/1999 | CA2327800A1 Process for evaluating chemical and biological assays |
10/28/1999 | CA2326670A1 Ikb and enhanced green fluorescent fusion protein |
10/28/1999 | CA2326623A1 Gene encoding syntaxin interacting protein |
10/28/1999 | CA2326621A1 Immobilized substrate, separation gels and method for detecting enzymatic activity |
10/28/1999 | CA2326498A1 Methods for reducing non-specific binding to a nucleic acid probe array |
10/28/1999 | CA2325864A1 Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy |
10/28/1999 | CA2325663A1 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis |
10/28/1999 | CA2325604A1 Mutants of the mycobacterium species and the use thereof for screening for antibiotic vectors |
10/28/1999 | CA2325391A1 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
10/28/1999 | CA2324995A1 Methods and products related to metabolic interactions in disease |
10/28/1999 | CA2324975A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof |
10/28/1999 | CA2324297A1 Sh2 domain-containing peptides |
10/28/1999 | CA2323571A1 Novel human k+ ion channel and therapeutic applications thereof |
10/27/1999 | EP0952453A1 Process and reagent for the determination of iron, free of interferences |
10/27/1999 | EP0952451A1 Dry analytical elements for the determination of protein |
10/27/1999 | EP0952450A1 Diagnostic reagent for Puumala virus infection |
10/27/1999 | EP0952449A2 Resistance measuring meter with voltage multiplier |
10/27/1999 | EP0952447A1 Gas sensor and its use as methan/propansensor |
10/27/1999 | EP0952440A2 Photometric readhead with light-shaping plate |
10/27/1999 | EP0952220A2 Method to predict active growth of bacteria adhered to a surface |
10/27/1999 | EP0952219A1 Recombinant proteins for the fusion of the porcine reproductive and respiratory syndrome virus and its use in diagnosis |
10/27/1999 | EP0952216A2 Solid phase supports with PNA and amidate tag compliments |
10/27/1999 | EP0952215A2 Protease for activating clotting factor VII |
10/27/1999 | EP0952213A2 Process for inducing an immune response mediated by NK-cells |
10/27/1999 | EP0951939A2 Storage container for analytical test elements |
10/27/1999 | EP0951704A1 Device for monitoring pollution caused by motor vehicles in an urban area |
10/27/1999 | EP0951647A2 Sample transfer |
10/27/1999 | EP0951646A1 THE IMMUNOENZIMATIC ASSAY FOR THE DIAGNOSIS OF EQUINE INFECTIOUS ANEMIA VIRUS DISEASE BY USING RECOMBINANT PROTEIN (rGP90) DERIVED FROM EQUINE INFECTIOUS ANEMIA VIRUS |
10/27/1999 | EP0951645A1 Method for characterization of abnormal cells |
10/27/1999 | EP0951644A1 Methods and devices for detecting spoilage in food products |
10/27/1999 | EP0951642A1 Apparatus and methods for preparing blood or plasma component solutions of known concentration |
10/27/1999 | EP0951564A1 Method for the detection of compounds that modulate the effects of the obese (ob) protein |
10/27/1999 | EP0951563A1 A new eia test using non-dentured hiv antigen for early detection of hiv infection |
10/27/1999 | EP0951552A2 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
10/27/1999 | EP0951551A2 Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily |
10/27/1999 | EP0951550A1 Mammalian cytokine related to il10 |
10/27/1999 | EP0951548A1 Mammalian icyp (iodocyanopindolol)receptor and its applications |
10/27/1999 | EP0951547A1 NOVEL SEQUENCES OF p56 PROTEINS WHICH AFFECT K-ATP CHANNELS |
10/27/1999 | EP0951480A1 Method and novel compounds for use therein |
10/27/1999 | EP0951469A1 Novel compounds |
10/27/1999 | EP0951453A2 Method of forming glasses |
10/27/1999 | EP0951360A1 Centrifuge apparatus for separating blood |
10/27/1999 | EP0951298A1 Diagnosis and treatment of pathological pregnancies |
10/27/1999 | EP0951297A1 Detection of antigens via oligonucleotide antibody conjugates |
10/27/1999 | EP0914596A4 Method and system for determining air/fuel ratio of an engine's combustion process from its exhaust emissions |
10/27/1999 | EP0848821B1 IgG/IgM RATIO FOR DETERMINING EFFECTIVENESS OF INTERFERON THERAPY IN INDIVIDUALS WITH HCV INFECTIONS |
10/27/1999 | EP0830601B1 Use of a phycobiliprotein-linker peptide complex as a fluorescent tracer |
10/27/1999 | EP0815431A4 Evanescent wave immunoassay system |
10/27/1999 | EP0772778B1 Method for the determination of the prethrombotic state |